The aim of this study is to assess the outcomes of breast conserving therapy operation depending on the type of surgical tool used: classic electrocoagulation with higher operative temperatures and high frequency electrocoagulation with lower operative temperatures. The investigators would assess the pain levels, length and amount of the lymphatic secretion as well as quality of life following breast conserving surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
150
During the BCT with SLND the investigators would use two types of electrocoagulation. The steps of the operation would remain the same in both arms, nevertheless the tool used would vary.
Department of Surgical Oncology
Gdansk, Pomeranian Voivodeship, Poland
RECRUITINGPain Control
Pain assessment would be performed using Visual Analogue Scale (VAS) at the days 1-5, 10 (+/- 2), 20 (+/- 2), 30 (+/- 2), and 12 weeks (+/- 2 days). SF - MPQ questionnaire would be filled in on admission, 10th (+/- 2) post-operative day and 12 weeks (+/- 2 days)after surgery.
Time frame: From the day before surgery up to 12 weeks (+/-2days) after surgery
Quality of life (QoL)
Pre-operative assessment of QoL would be performed by psychologist using questionnaires: CISS, HADS - M, Eysencka. Postoperative assessment of QoL would be performed using QLQ C30 and QLQ BR 23 questionnaires 12 weeks (+/- 2 days)after surgery
Time frame: From the day before surgery up to 12 weeks (+/-2days) after surgery
Length of lymphatic secretion
Number of days of lymphatic secretion would be assessed.
Time frame: From the day before surgery up to 12 weeks (+/-2days) after surgery
Amount of lymphatic secretion
Amount of lymphatic secretion would be measured until it stops on daily basis.
Time frame: From the day before surgery up to 12 weeks (+/-2days) after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.